0.01Open0.01Pre Close50 Volume109 Open Interest93.00Strike Price50.00Turnover114.90%IV14.45%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type-0.0047Delta0.0021Gamma10870.00Leverage Ratio-0.0100Theta0.0000Rho-51.12Eff Leverage0.0008Vega
Novo-Nordisk A/S Stock Discussion
FLOW trial evaluated the risk reduction associated with treatment with Ozempic ® in chronic kidney disease-related events in adults with type 2 diabetes and chronic kidney disease (CKD). FLOW, semag...
The agreement The acquisition of the three production sites was announced on February 5. On May 29, Catalent shareholders voted in favor of the pending transac...
$Novo-Nordisk A/S (NVO.US)$
new
for some reason the profile says its lly
it's so greeen
Add...
No comment yet